Enliven Therapeutics
ELVN
#4344
Rank
HK$18.81 B
Marketcap
HK$314.55
Share price
13.14%
Change (1 day)
89.74%
Change (1 year)

Earnings for Enliven Therapeutics (ELVN)

Earnings in 2024: -HK$0.82 Billion

According to Enliven Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.82 Billion a decrease over its 2023 earnings that were of -HK$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enliven Therapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024-HK$0.82 Billion25.17%
2023-HK$0.66 Billion115.33%
2022-HK$0.31 Billion